Condensed Consolidated Statements of Operations - USD ($) $ in Thousands	3 Months Ended
Mar. 31, 2026	Mar. 31, 2025
Income Statement [Abstract]
Revenues	$ 61,457	$ 48,560
Cost of goods sold	15,268	13,627
Gross profit	46,189	34,933
Costs and expenses:
Sales and marketing	28,633	21,045
Research and development	7,517	6,091
General and administrative	12,871	9,458
Total costs and expenses	49,021	36,594
Loss from operations	(2,832)	(1,661)
Other income (expense):
Investment income	768	272
Interest expense	(694)	(2,250)
Loss on extinguishment of debt	(16,849)	0
Change in fair value of debt derivative liabilities	0	(158)
Other income (expense), net	23	(37)
Total other expense, net	(16,752)	(2,173)
Net loss	$ (19,584)	$ (3,834)
Weighted average common shares outstanding - basic (in shares)	51,591,504	45,204,076
Weighted average common shares outstanding - diluted (in shares)	51,591,504	45,204,076
Net loss per common share - basic (in USD per share)	$ (0.38)	$ (0.08)
Net loss per common share - diluted (in USD per share)	$ (0.38)	$ (0.08)

The aggregate costs related to goods produced and sold and services rendered by an entity during the reporting period. This excludes costs incurred during the reporting period related to financial services rendered and other revenue generating activities.

Name:	us-gaap_CostOfGoodsAndServicesSold
Namespace Prefix:	us-gaap_
Data Type:	xbrli:monetaryItemType
Balance Type:	debit
Period Type:	duration

- Definition

Total costs of sales and operating expenses for the period.